Evidence map›Paper›PMID 36978386›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Epigenetic and Drug Response Modulation of Epigalocaten-In-3-Gallate in

Ana Rita Mira, Ana Sofia Zeferino, Raquel Inácio, Mariana Delgadinho, Miguel Brito, Cecília R C Calado, Edna Ribeiro

Open access · goldFull text read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ana Rita MiraH&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 Lisboa, Portugal.
Ana Sofia ZeferinoEscola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 Lisboa, Portugal.
Raquel InácioCIMOSM-Centro de Investigação em Modelação e Otimização de Sistemas Multifuncionais, ISEL-Instituto Superior de Engenharia de Lisboa, Instituto, Politécnico de Lisboa, R. Conselheiro Emidio Navarro 1, 1959-007 Lisboa, Portugal.
Mariana DelgadinhoH&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 Lisboa, Portugal.ORCID 0000-0003-0586-9154
Miguel BritoH&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 Lisboa, Portugal.ORCID 0000-0001-6394-658X
Cecília R C CaladoCIMOSM-Centro de Investigação em Modelação e Otimização de Sistemas Multifuncionais, ISEL-Instituto Superior de Engenharia de Lisboa, Instituto, Politécnico de Lisboa, R. Conselheiro Emidio Navarro 1, 1959-007 Lisboa, Portugal.ORCID 0000-0002-5264-9755
Edna RibeiroH&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, Av. D. João II, lote 4.69.01, Parque das Nações, 1990-096 Lisboa, Portugal.ORCID 0000-0003-1316-7750
Instituto Politécnico de Lisboa · PT

Funding

Instituto Politécnico de Lisboa IPL/2020/ EpiResistanceSA _ESTeSL
6 · The paper itself

Abstract

Healthcare-associated methicillin-resistant

Indexed as

drug resistance modulatorsdrug resistance phenotypesepigallocatechin-3-gallate (EGCG)epigenetic modulatorhealthcare-associated S. aureus infectionssynergistic effects

Identifiers

PMID36978386
PMCPMC10044528
OpenAlexW4323318895

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read46
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.